Dr. Paul Szabolcs
Overview
Paul Szabolcs, MD, received his medical degree summa cum laude at the Semmelweis University School of Medicine in Budapest, Hungary. He completed his training in pediatrics at Bellevue Hospital/NYU Medical Center and subsequently trained in hematology/oncology at the Memorial Sloan Kettering Cancer Center/Cornell-NY Hospital Medical Center in New York City. He received postdoctoral laboratory training at the Memorial Sloan Kettering Cancer Center and at Rockefeller University in the Department of Physiology and Cellular Immunology.
Dr. Szabolcs is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Graft Versus Host Disease (GvHD), Severe Combined Immunodeficiency (SCID), Leukemia, Systemic Sclerosis (SSc), and Bone Marrow Transplant.
His clinical research consists of co-authoring 42 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
Locations
4401 Penn Avenue, Pittsburgh, PA 15224
Additional Areas of Focus
Dr. Szabolcs has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
BMT At Pediatric Hematology Oncology In Lawrenceville
Randy Windreich, MD, is a pediatric bone marrow transplant specialist and is board-certified in pediatrics and pediatric hematology-oncology by the American Board of Pediatrics. He is clinical director of the Division of Blood and Marrow Transplantation and Cellular Therapy at UPMC Children’s Hospital of Pittsburgh and associate professor of pediatrics at the University of Pittsburgh School of Medicine. Dr. Windreich is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Graft Versus Host Disease (GvHD), Infantile Neutropenia, Beta-Mannosidosis, Chediak-Higashi Syndrome, and Bone Marrow Transplant.
BMT At Pediatric Hematology Oncology In Lawrenceville
Archana Ramgopal, DO, specializes in pediatric cellular therapy and is board-certified by the American Board of Pediatrics. She practices at UPMC Children's Hospital of Pittsburgh. Dr. Ramgopal received her medical degree from Lake Erie College of Osteopathic Medicine and completed her residency at Cleveland Clinic, followed by a fellowship at the University of Pittsburgh School of Medicine. Dr. Ramgopal is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Saddle Pulmonary Embolism, Beta Thalassemia, and Bone Marrow Transplant.
BMT At Pediatric Hematology Oncology In Lawrenceville
Paulina Horvei, MD, is board-certified in pediatric hematology-oncology and pediatrics by the American Board of Pediatrics. She practices at UPMC Children's Hospital of Pittsburgh. Dr. Horvei received her medical degree from the University of Chile and completed her residency at Icahn School of Medicine at Mount Sinai, followed by fellowships at Mayo Clinic College of Medicine and Science and the University of California San Francisco School of Medicine. Dr. Horvei is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Alpha Thalassemia, Systemic Sclerosis (SSc), Thalassemia, and Immune Thrombocytopenic Purpura (ITP).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bone Marrow TransplantDr. Szabolcs isDistinguished. Learn about Bone Marrow Transplant.
- Advanced
- Graft Versus Host Disease (GvHD)Dr. Szabolcs isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- Experienced
- Aase SyndromeDr. Szabolcs isExperienced. Learn about Aase Syndrome.
- Acquired Amegakaryocytic ThrombocytopeniaDr. Szabolcs isExperienced. Learn about Acquired Amegakaryocytic Thrombocytopenia.
- Aplastic AnemiaDr. Szabolcs isExperienced. Learn about Aplastic Anemia.
- Beta-MannosidosisDr. Szabolcs isExperienced. Learn about Beta-Mannosidosis.
- Chediak-Higashi SyndromeDr. Szabolcs isExperienced. Learn about Chediak-Higashi Syndrome.
- Chronic Granulomatous DiseaseDr. Szabolcs isExperienced. Learn about Chronic Granulomatous Disease.